Concurrent use of DOACs and pharmacodynamic interacting drugs is associated with an increased risk of major bleeding compared with patients using DOACs alone: Nested case-control study in UK CPRD

Zhang, Yumao ; De Boer, Anthonius ; Gardarsdottir, Helga ; Van Den Ham, Hendrika A ; Maitland-Van Der Zee, A.H ; Souverein, Patrick C

2018

Texto completo disponível